Astra
Zeneca COVID-19 Coronavirus Vaccine" and a syringe are seen in front of a displayed Astra
Zeneca logo (Reuters) - Astra
Zeneca (NASDAQ:AZN) Plc said on Sunday a review of safety data of people vaccinated with its COVID-19 vaccine has shown no evidence of an increased risk of blood clots.
Zeneca finds no evidence of increased blood clot risk from vaccine (Image not shown due to low ratings)
Images were hidden due to low ratings.